A tolerogenic mRNA-LNP vaccine alleviates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis
Science Bulletin · 2026-09 · 71 (17) · 4472-4489
DOI: 10.1016/j.scib.2026.08.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Bulletin, 2026-09. Verfasst von Yi Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology, PLA, Third Military Medical University (Army Medical University), Chongqing 400038, China. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, RNA, Messenger, Demyelinating Diseases, Neuroinflammatory Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Basic Science and Advanced Technology Research Program.
Abstract (Originalsprache)
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS). Current non-specific immunosuppressive therapies carry risks of infection and malignancy. Antigen-specific tolerance induction presents a promising alternative. Here, we developed a messenger RNA-lipid nanoparticle (mRNA-LNP) vaccine (LiH-LNPs) encoding a tandem fusion of epitopes from three MS-associated myelin antigens. LiH-LNPs alleviated inflammatory infiltration and demyelination in experimental autoimmune encephalomyelitis (EAE). Single-cell RNA sequencing revealed that LiH-LNPs reshaped the spinal cord microenvironment toward inflammation resolution by reducing the abundance and inflammatory activity of infiltrating myeloid cells and activated microglia, inducing apoptosis of encephalitogenic T cells while increasing regulatory T (Treg) cell abundance and suppressive activity. These findings provide mechanistic insights into antigen-specific immunotherapy for MS and highlight the potential application of mRNA vaccine-based antigen-specific therapy for autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Immunology, PLA, Third Military Medical University (Army Medical University), Chongqing 400038, China.
- Chongqing International Institute for Immunology, Chongqing 401338, China. Electronic address: dongyezc@163.com.
- Department of Urology, The First Hospital of China Medical University, Shenyang 110001, China.
- Chongqing International Institute for Immunology, Chongqing 401338, China; School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.
- Department of Histology and Embryology, Chongqing Key Laboratory of Brain Development and Cognition, Brain and Intelligence Research Key Laboratory of Chongqing Education Commission, PLA, Third Military Medical Universi…
- Chongqing International Institute for Immunology, Chongqing 401338, China.
Förderung
- National Natural Science Foundation of China
- Chongqing Basic Science and Advanced Technology Research Program
Zitieren
APA
Song, Y., Dongye, Z., Yao, J., Zhao, X., Mo, T., Yang, S., Sun, C., Zhao, T., Li, J., & Wu, Y. (2026). A tolerogenic mRNA-LNP vaccine alleviates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis. Science Bulletin, 71(17), 4472-4489. https://doi.org/10.1016/j.scib.2026.08.017
Vancouver
Song Y, Dongye Z, Yao J, Zhao X, Mo T, Yang S, et al. A tolerogenic mRNA-LNP vaccine alleviates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis. Science Bulletin. 2026;71(17):4472-4489. doi:10.1016/j.scib.2026.08.017
BibTeX
@article{Song2026,
author = {Song, Yi and Dongye, Zhangchi and Yao, Jiaxi and Zhao, Xiaonan and Mo, Tao and Yang, Shiyu and Sun, Cong and Zhao, Tingting and Li, Jian and Wu, Yuzhang},
title = {A tolerogenic mRNA-LNP vaccine alleviates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis},
journal = {Science Bulletin},
year = {2026},
volume = {71},
number = {17},
pages = {4472--4489},
doi = {10.1016/j.scib.2026.08.017}
}
EUVIMED